3821
|
ABT-263
|
Potent, selective and orally bioavailable inhibitor of B-cell lymphoma-2 (BCL-2) family proteins |
Inquire |
3827
|
AMG-511
|
Orally bioavailable, highly potent and selective pan-class I phosphatidylinositol-3 kinase (PI3K) inhibitor |
Inquire |
2757
|
Asciminib
|
Potent and selective allosteric BCR-ABL1 inhibitor |
€120.00 |
3814
|
AZD4320
|
BH3-mimetic inhibitor of BCL-2 protein |
Inquire |
3833
|
AZD5153 HNT salt
|
Potent, selective, and orally available BET/BRD4 bromodomain inhibitor |
Inquire |
3832
|
BAY-1816032
|
Potent and selective BUB1 (Mitotic checkpoint serine/threonine-protein kinase) inhibitor |
Inquire |
3813
|
BMS-911543
|
Potent, selective and orally active inhibitor of JAK2 |
Inquire |
3830
|
GSK1904529A
|
Potent, selective and orally active inhibitor of the insulin-like growth factor-1 receptor (IGF-1R) |
Inquire |
3829
|
MLN7243
|
Cell permeable small molecule inhibitor targeting ubiquitin-activating enzymes (UAE, also known as E1 enzymes) |
Inquire |
3788
|
NE52-QQ57
|
Selective and orally bioavailable GPR4 antagonist |
€160.00 |
3784
|
PGP-4008
|
Selective P-glycoprotein (Pgp) inhibitor |
€120.00 |
3676
|
PKN3 inhibitor compound 16
|
Potent, cell-active protein kinase novel 3 (PKN3) inhibitor |
€130.00 |
3804
|
Sabizabulin
|
Orally bioavailable and highly potent tubulin polymerization inhibitor |
€220.00 |
3828
|
SCH900776 dihydrochloride
|
Potent, selective and orally bioavailable inhibitor of CHK1 |
Inquire |
3675
|
VU6036720 hydrochloride
|
First potent and selective inhibitor of heteromeric Kir4.1/5.1 inward rectifier potassium channels |
€130.00 |
3799
|
VU6036721 hydrochloride
|
Inactive enantiomer of VU6036720 hydrochloride |
€130.00 |
3836
|
VX-11e
|
Potent, selective, and orally bioavailable inhibitor of ERK2 |
Inquire |